ATARA Biotherapeutics (ATRA) Tops Q2 EPS by 19c

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q2 EPS of $0.19. Revenue for the quarter came in at $17.58 million.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
• Alibaba (BABA) Misses Q2 EPS by 220c
• The TJX Companies (TJX) PT Raised to $198 at UBS